Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing. International Medical Research Journal, v. 11, n. 1, 9 Sep.2026.